electroCore, Inc. (ECOR)
| Market Cap | 88.13M+85.4% |
| Revenue (ttm) | n/a+33.5% |
| Net Income | n/a-11.5% |
| EPS | n/a-3.0% |
| Shares Out | 9.02M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 7,009 |
| Open | 9.65 |
| Previous Close | 9.72 |
| Day's Range | 9.55 - 10.05 |
| 52-Week Range | 4.41 - 12.70 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | n/a |
| Earnings Date | n/a |
electroCore, Inc. has a live Insider Score.
Scored on 3 qualifying trades from 2 insiders in the last 90 days.
About ECOR
electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an app-enabled general wellness product. It also offers non-invasive bioelectronic therapies for the treatment of chronic pain and wellness conditions. In addition, the company offers TAC-STIM for human performance and gammaCore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$ECOR stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in ECOR holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by ECOR's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
ECOR Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New ECOR patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ECOR from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in ECOR
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $1.34M |
| VXFVanguard Extended Market ETF | $649.13K |
| GWXState Street SPDR S&P International Small Cap ETF | $540.02K |
| IWCiShares Micro-Cap ETF | $188.00K |
Estimated from each fund’s disclosed top holdings × AUM
ECOR Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from ECOR’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score